AmeriCann Reports Q2 2022 Results
A summary of operational highlights included the following:
AmeriCann’s Operating Revenue from Building 1 increased over 36% from the quarter ended June 30, 2021, to the quarter ending June 30, 2022. Net Income
Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder
Awakn Life Sciences Corp. (OTCQB: AWKNF), the biotech company focused on addiction treatments, has signed a licensing partnership agreement with US ketamine therapy clinics owner Revitalist Lifestyle and Wellness Ltd.
Who Are The Most Impactful Cannabis Executives Of 2022? Top Award Show Will Determine Who’s #1
After the awesome Cannabis Capital Conference in Miami during 4/20 week, Benzinga is ready to go again in Chicago on September 13-14.
Cannabis Global Provides Patent Applications Update – For Its Cannabis Nanoparticles And Insect Produced Cannabosides
Cannabis Global, Inc. (OTCPK:CBGL) provided an update concerning the company's patent applications, especially relating to its application to protect inventions and processes for cannabis nanoparticles.
iAnthus Reports Losses, Q2 Revenue Drops 20% YoY
iAnthus Capital Holdings, Inc. (OTCPK:ITHUF) (CSE:IAN) Q2 2022 revenue was $43.5 million, a sequential increase of 2% from Q1 2022 and a decrease of 20% from the same period in the prior year.
Q2 2022 Financial Highlights
Despite Lower Equipment Demand In The Cannabis Market urban-gro Q2 Revenue Grows Thanks To This
urban-gro, Inc. (NASDAQ: UGRO) released second quarter financial results, revealing revenue was $16.3 million, an increase of 27%, compared to $12.8 million in the prior year period.
This Canadian Cannabis LP Reports Strong Sales Trends In Q2 But Analyst Remains Concerned, Here’s Why
Auxly Cannabis Group Inc. (OTCQX: CBWTF) (TSX:XLY) reported its financial results
Greenlane Q2 Revenue Grows 15% YoY, Provides Outlook
Greenlane Holdings, Inc. (NASDAQ: GNLN) Q2 2022 revenue increased 15% to $39.9 million, compared to $34.7 million in Q2 2021.
Financial Results
TILT Q2 Revenue Slightly Slides YoY, Saved By Growing Cannabis Operations
TILT Holdings Inc. (OTCQX: TLLTF) (NEO:TILT) Q2 2022 revenue was $47.1 million, a 2.88% decrease compared to $48.5 million in the prior year.